September 30, 2020 by Chain Drug Review
BD, BD Veritor Plus System, Roland Goette, SARS-CoV-2 antigen test
Pharmacy, Supplier News
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) announced on Wednesday that its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor Plus System has been CE marked to the IVD Directive (98/79/EC). The new test delivers results in 15 minutes on an easy-to-use, portable instrument, which is a critical improvement in turnaround
August 10, 2020 by Chain Drug Review
BD, BD Foundation, BD Helping Build Healthy Communities initiative, Tom Polen
Leading Headlines, Pharmacy
FRANKLIN LAKES, N.J. — BD and its charitable affiliate BD Foundation have committed $7.8 million in monetary grants and product donations over the next three years to support the continued expansion of the BD Helping Build Healthy Communities initiative. This is a unique public-private partnership launched in 2013 and implemented jointly by Direct Relief and the National Association
July 6, 2020 by Chain Drug Review
BD, BD Veritor Plus System for Rapid Detection of SARS-CoV-2 Assay, Dave Hickey, The BD Veritor System
Pharmacy, Supplier News
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Co.) announced Monday that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor Plus System. The launch of this new assay that delivers results in 15 minutes on an
March 31, 2020 by Chain Drug Review
BD, BioMedomics, COVID-19, Serology tests
Pharmacy, Supplier News
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson) and BioMedomics announced the release of a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19 in as little as 15 minutes. The new test, developed and manufactured by BioMedomics, will be available through BD and distributed exclusively by Henry Schein, Inc.
March 26, 2020 by Chain Drug Review
BD, COVID-19
Pharmacy, Supplier News
BD issued the following statement on how the company is working with companies and agencies during the COVID-19 outbreak: FRANKLIN LAKES, N.J. — BD is closely monitoring the COVID-19 (coronavirus) situation across the world and guidance from the U.S. Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and health officials in
October 3, 2017 by Bill Schiffner
BD, BD Ultra-Fine micro pen needles, Becton Dickinson, diabetes care, Nabil Shabshab
Supplier News
FRANKLIN LAKES, N.J.— Becton Dickinson (BD) has rolled out its new 6mm x 32G Ultra-Fine micro pen needle. With the launch, BD is providing health care providers with an additional needle length option for people with diabetes who inject insulin. The introduction of the new pen needle rounds out the BD Ultra-Fine pen needle portfolio,